Is Nvidia stock price still a buy after its massive run? Dive into the real driversâAI demand, data center growth, and valuation risksâwith firsthand insights from a long-time observer.
How is AI accelerating drug discovery? From target identification to clinical trials, explore real-world applications, tools, and pitfalls learned over a decade in the field.
Which companies are actually using AI to discover and develop new drugs? I dive deep into Insilico Medicine, Recursion, and others with real pipeline examples.
Curious how BioNeMo Framework transforms drug discovery? This guide covers architecture, real-world use cases, hands-on setup tips, and pitfalls to avoid. No fluff, just practical insights.
What percentage of GDP is PCE? Discover the exact figure (around 68%) and why this consumer spending metric is the most watched economic indicator for investors and policymakers.
Is NVIDIA's stock decline a buying opportunity or a warning sign? We break down the real causes behind the sell-off, from valuation concerns to competitive threats, and share what smart investors are watching now.